Simulect - Immunosuppressive to prevent acute rejection in renal transplant patients

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1998年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：620 / 621
页数：2
相关论文
共 50 条
  • [1] Basiliximab (Simulect®) significantly reduces the incidence of acute rejection in renal transplant patients receiving triple therapy with Azathioprine.
    Ponticelli, C
    Yussim, A
    Cambi, V
    Legendre, C
    Rizzo, G
    Salvadori, M
    Kahn, D
    Kashi, SH
    Salmela, K
    Fricke, L
    Garcia-Martinez, J
    Lechler, R
    Girault, D
    TRANSPLANTATION, 2000, 69 (08) : S156 - S156
  • [2] The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation
    Chilcott, JB
    Holmes, MW
    Walters, S
    Akehurst, RL
    Nashan, B
    TRANSPLANT INTERNATIONAL, 2002, 15 (9-10) : 486 - 493
  • [3] Glomerulitis in acute rejection of renal transplant patients
    Valente, M.
    Della Barbera, M.
    Furian, L.
    Marchini, F.
    Cardillo, M.
    Marino, S.
    Rigotti, P.
    Aiello, F. B.
    HISTOPATHOLOGY, 2010, 57 : 235 - 236
  • [4] Delayed cyclosporine administration following simulect induction does not increase acute rejection in renal transplant recipients.
    Pelletier, RP
    Bumgardner, GL
    Davies, EA
    Elkhammas, EA
    Henry, ML
    Ferguson, RM
    TRANSPLANTATION, 2000, 69 (08) : S158 - S159
  • [5] New study shows simulect reduces acute rejection and increases graft survival in diabetic renal transplant recipients
    不详
    DIALYSIS & TRANSPLANTATION, 2000, 29 (12) : 769 - 770
  • [6] Basiliximab Simulect® -: Immunosuppressant treatment of transplant rejection
    不详
    DRUGS OF THE FUTURE, 2000, 25 (07) : 738 - 739
  • [7] Acute Rejection in Renal Transplant Patients of a Hospital in Bogota, Colombia
    Garcia, P.
    Huerfano, M.
    Rodriguez, M.
    Caicedo, A.
    Berrio, F.
    Gonzalez, C.
    INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2016, 7 (03): : 161 - 166
  • [8] Proteomic urinalysis of renal transplant patients with acute rejection.
    Hampel, DJ
    Schnoelzer, M
    Reinke, P
    Frei, U
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 66A - 66A
  • [9] New immunosuppressive drugs for prevention and treatment of rejection in renal transplant
    Segoloni, Giuseppe P.
    Quaglia, Marco
    JOURNAL OF NEPHROLOGY, 2006, 19 (05) : 578 - 586
  • [10] Basiliximab (Simulect®) reduces the rate and severity of acute rejection in adult liver transplant recipients.
    Neuhaus, P
    Nashan, B
    Clavien, PA
    Kittur, D
    Salizzoni, M
    Rimola, A
    Abeywickrama, K
    Ortmann, CE
    Chodoff, L
    Hall, M
    Korn, A
    TRANSPLANTATION, 2000, 69 (08) : S118 - S118
12345